428 related articles for article (PubMed ID: 28213089)
1. Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling.
Grabner GF; Zimmermann R; Schicho R; Taschler U
Pharmacol Ther; 2017 Jul; 175():35-46. PubMed ID: 28213089
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-induced Neuroinflammation.
Grabner GF; Eichmann TO; Wagner B; Gao Y; Farzi A; Taschler U; Radner FP; Schweiger M; Lass A; Holzer P; Zinser E; Tschöp MH; Yi CX; Zimmermann R
J Biol Chem; 2016 Jan; 291(2):913-23. PubMed ID: 26565024
[TBL] [Abstract][Full Text] [Related]
3. Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice.
Vujic N; Schlager S; Eichmann TO; Madreiter-Sokolowski CT; Goeritzer M; Rainer S; Schauer S; Rosenberger A; Woelfler A; Doddapattar P; Zimmermann R; Hoefler G; Lass A; Graier WF; Radovic B; Kratky D
Atherosclerosis; 2016 Jan; 244():9-21. PubMed ID: 26584135
[TBL] [Abstract][Full Text] [Related]
4. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance.
Taschler U; Radner FP; Heier C; Schreiber R; Schweiger M; Schoiswohl G; Preiss-Landl K; Jaeger D; Reiter B; Koefeler HC; Wojciechowski J; Theussl C; Penninger JM; Lass A; Haemmerle G; Zechner R; Zimmermann R
J Biol Chem; 2011 May; 286(20):17467-77. PubMed ID: 21454566
[TBL] [Abstract][Full Text] [Related]
5. Brain monoglyceride lipase participating in endocannabinoid inactivation.
Dinh TP; Carpenter D; Leslie FM; Freund TF; Katona I; Sensi SL; Kathuria S; Piomelli D
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10819-24. PubMed ID: 12136125
[TBL] [Abstract][Full Text] [Related]
6. Assay of Monoacylglycerol Lipase Activity.
Jung KM; Piomelli D
Methods Mol Biol; 2016; 1412():157-68. PubMed ID: 27245902
[TBL] [Abstract][Full Text] [Related]
7. Assay of Monoacylglycerol Lipase Activity.
Jung KM; Piomelli D
Methods Mol Biol; 2023; 2576():285-297. PubMed ID: 36152196
[TBL] [Abstract][Full Text] [Related]
8. Chemical approaches to therapeutically target the metabolism and signaling of the endocannabinoid 2-AG and eicosanoids.
Kohnz RA; Nomura DK
Chem Soc Rev; 2014 Oct; 43(19):6859-69. PubMed ID: 24676249
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons.
Keimpema E; Tortoriello G; Alpár A; Capsoni S; Arisi I; Calvigioni D; Hu SS; Cattaneo A; Doherty P; Mackie K; Harkany T
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1935-40. PubMed ID: 23319656
[TBL] [Abstract][Full Text] [Related]
10. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding.
Keimpema E; Barabas K; Morozov YM; Tortoriello G; Torii M; Cameron G; Yanagawa Y; Watanabe M; Mackie K; Harkany T
J Neurosci; 2010 Oct; 30(42):13992-4007. PubMed ID: 20962221
[TBL] [Abstract][Full Text] [Related]
11. Fatty acid amide hydrolase but not monoacyl glycerol lipase controls cell death induced by the endocannabinoid 2-arachidonoyl glycerol in hepatic cell populations.
Siegmund SV; Wojtalla A; Schlosser M; Zimmer A; Singer MV
Biochem Biophys Res Commun; 2013 Jul; 437(1):48-54. PubMed ID: 23806692
[TBL] [Abstract][Full Text] [Related]
12. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus.
Hashimotodani Y; Ohno-Shosaku T; Kano M
J Neurosci; 2007 Jan; 27(5):1211-9. PubMed ID: 17267577
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
[TBL] [Abstract][Full Text] [Related]
15. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol.
Dinh TP; Kathuria S; Piomelli D
Mol Pharmacol; 2004 Nov; 66(5):1260-4. PubMed ID: 15272052
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity.
Chon SH; Douglass JD; Zhou YX; Malik N; Dixon JL; Brinker A; Quadro L; Storch J
PLoS One; 2012; 7(8):e43962. PubMed ID: 22937137
[TBL] [Abstract][Full Text] [Related]
17. Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons.
Dotsey EY; Jung KM; Basit A; Wei D; Daglian J; Vacondio F; Armirotti A; Mor M; Piomelli D
Chem Biol; 2015 May; 22(5):619-28. PubMed ID: 26000748
[TBL] [Abstract][Full Text] [Related]
18. Refined homology model of monoacylglycerol lipase: toward a selective inhibitor.
Bowman AL; Makriyannis A
J Comput Aided Mol Des; 2009 Nov; 23(11):799-806. PubMed ID: 19543978
[TBL] [Abstract][Full Text] [Related]
19. CAY10499, a novel monoglyceride lipase inhibitor evidenced by an expeditious MGL assay.
Muccioli GG; Labar G; Lambert DM
Chembiochem; 2008 Nov; 9(16):2704-10. PubMed ID: 18855964
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation.
Nomura DK; Morrison BE; Blankman JL; Long JZ; Kinsey SG; Marcondes MC; Ward AM; Hahn YK; Lichtman AH; Conti B; Cravatt BF
Science; 2011 Nov; 334(6057):809-13. PubMed ID: 22021672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
